药物对比
Alogliptin vs Rosiglitazone
Alogliptin是治疗2型糖尿病的有黑框警告的DPP-4抑制剂，而Rosiglitazone是无黑框警告的噻唑烷二酮类药物，可改善胰岛素敏感性。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes who have not achieved adequate glycemic control with metformin or other first-line agents.
结论
Both Alogliptin and Rosiglitazone are effective antidiabetic medications for type 2 diabetes but should be selected based on individual patient factors.
全部药物对比